A Prospective Multicenter Post Approval Study to Evaluate the Long-term Safety and Efficacy of the Resolute Integrity in the Japanese All-comers Patients With Coronary Artery Disease (PROPEL)

CompletedOBSERVATIONAL
Enrollment

1,204

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

May 31, 2014

Study Completion Date

April 30, 2016

Conditions
Coronary Artery DiseaseDrug-eluting Stent
Trial Locations (1)

105-0013

Non-profit organization Associations for Establishment of Evidence in Interventions, Minato-ku, Tokyo

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Medtronic Vascular

INDUSTRY

lead

Associations for Establishment of Evidence in Interventions

OTHER